Jonathan Schechter - 29 Mar 2023 Form 4 Insider Report for Synaptogenix, Inc. (SNPX)

Role
Director
Signature
/s/ Robert Weinstein, Attorney-in-fact
Issuer symbol
SNPX
Transactions as of
29 Mar 2023
Net transactions value
$0
Form type
4
Filing time
31 Mar 2023, 16:18:39 UTC
Previous filing
20 Dec 2022
Next filing
01 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNPX Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 29 Mar 2023 Common Stock, par value $0.0001 per share 20,000 $0.8700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following March 29, 2023.